Skip to main content
logo
Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
4.810
+0.260 (5.71%)
Aug 7, 2026, 4:00 PM EDT - Market closed

Lexeo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
378725218358--
Market Cap Growth
46.94%233.12%-39.15%---
Enterprise Value
192.01551.02106.01247.7700
Last Close Price
4.819.936.5813.42--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
1.542.941.863.15--
P/TBV Ratio
1.362.161.790.63--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.020.060.080.150
Net Debt / Equity Ratio
-0.80-0.70-0.95-0.970.562.44
Net Debt / EBITDA Ratio
1.901.601.061.611.062.68
Net Debt / FCF Ratio
1.891.761.371.841.163.06
Asset Turnover
-0000.010.02
Quick Ratio
13.6110.815.327.055.3918.24
Current Ratio
14.1611.215.527.215.5818.35
Return on Equity (ROE)
-36.60%-55.00%-85.37%-71.54%-58.84%-65.27%
Return on Assets (ROA)
-37.68%-52.57%-73.77%-57.85%-51.73%-60.91%
Return on Invested Capital (ROIC)
-144.69%-205.25%-508.38%-360.79%-603.94%-56736.10%
Return on Capital Employed (ROCE)
-40.07%-58.12%-85.76%-66.75%-57.05%-64.05%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-98.55%-68.76%-493.67%-228.42%-5.00%-7.72%
Total Shareholder Return
-98.55%-68.76%-493.67%-228.42%-5.00%-7.72%
SEC Filings: 10-K · 10-Q